Tradestie Institutional Equity Comparison Engine

AVDL vs BCRX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while BCRX counters with relative strength in Valuation. Fundamentally, AVDL trades at 28.8x Forward P/E with 2.5% operating margin (+54.9% YoY revenue) versus BCRX at 8.4x Forward P/E and 48.8% operating margin (+13.1% YoY). In options structure, AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against BCRX sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BCRX
AVDL 28.8x vs BCRX 8.4x Fwd P/E
Growth & Margin Winner AVDL
Op Margin 2.5% vs 48.8% ยท YoY +54.9% vs +13.1%
Momentum & Technical Winner AVDL
1Y +138.1% vs +4.2% ยท 52W Pos 89% vs 20%
Options & Structure Winner AVDL
UNCLASSIFIED (<1st %ile IV) vs BREAKDOWN (10th %ile IV)
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
BCRX NASDAQ
BioCryst Pharmaceuticals Inc
Biological Products, (No Disgnostic Substances)
$7.22
-1.37% 1D
Market Cap $1.9B
1M Return -7.2%
1Y Return +4.18%
Forward P/E 8.4x
Unified AI Score
40.6 / 100 SELL
Tech 15.0 Fund 48.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AVDL +138.06% BCRX +4.18% Spread: +5.02 pp (BCRX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AVDL TTM Op. Margin: 2.5% BCRX TTM Op. Margin: 48.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVDL vs BCRX. Trailing 12-month operating profitability (AVDL 2.5% vs BCRX 48.8%) and valuation multiples (AVDL 28.8x vs BCRX 8.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AVDL (7) vs BCRX (3)
Institutional Metric AVDL BCRX Criterion Row Winner
Market Capitalization Scale $2.1B $1.9B Larger Scale AVDL
Trailing P/E Ratio Valuation 16.8x 12.4x Lower Multiple BCRX
Forward P/E Ratio Valuation 28.8x 8.4x Lower Multiple BCRX
Revenue Growth (YoY) Growth +54.9% +13.1% Higher Growth AVDL
Operating Margin (TTM) Profitability 2.5% 48.8% Higher Margin BCRX
Net Profit Margin Profitability -0.1% -37.4% Higher Margin AVDL
Return on Equity (ROE) Capital Efficiency -0.3% -1925.4% Higher ROE AVDL
52-Week Range Position Momentum 89% ($6โ€“$24) 20% ($6โ€“$11) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 0.14ฮฒ ยท 2% Vol 0.66ฮฒ ยท 42% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 62.9 / 100 (BUY) 40.6 / 100 (SELL) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AVDL vs BCRX Buy Guide
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BCRX BREAKDOWN
96d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live BCRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AVDL nor BCRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.